SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Codexis Reports 3–4x siRNA Potency in Initial In Vitro Results

Codexis also reported product quality above 90% at 100-gram scale, nearly halved cycle time and consistent performance across three orders of magnitude in scale.

CDXS

Related stories